EZH2 and cancer: Inactivation of EZH2 inhibits metastasis, tumor angiogenesis and growth (Chang et al., 2006), and small molecule-mediated inhibition of the enzymatic function of Ezh2 may allow pharmacological treatment of cancer (Crea et al., 2012).